Covestor LTD Morphic Holding, Inc. Transaction History

Covestor LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$21.33 - $59.42 $21 - $59	-1 Reduced 25.0%	3 $0
Q3 2022 Nov 14, 2022	SELL	$22.23 - $33.37 $22 - $33	-1 Reduced 20.0%	4 $0
Q2 2022 Aug 10, 2022	SELL	$19.74 - $43.01 $19 - $43	-1 Reduced 16.67%	5 $0
Q1 2022 May 13, 2022	SELL	$36.25 - $52.02 $72 - $104	-2 Reduced 25.0%	6 $0
Q4 2021 Feb 10, 2022	BUY	$43.27 - $65.72 $346 - $525	8 New	8 $0

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.